Cardiology is a branch of medicine involving the study of structures of heart and their functions. Cardiovascular Ultrasound Market has increased due to increase in the incidence of cardiovascular diseases, changing lifestyle of people, increase in incidence of diabetes and other risk factors favoring the growth of this market. Global Market of Cardiovascular Ultrasound Imaging is expected to reach US$ 1.72 billion in 2023 from US$ 1.45 billion in 2016 with a CAGR of approximately 6.3% during the forecast period 2017-2023.
Cardiovascular diseases gain a huge attention due to increasing prevalence. Due to increasing number of deaths from cardiovascular diseases, number of companies are in a race for the introduction of the better devices and accessories for the treatment. Moreover, increasing prevalence of the cardiovascular is expected to support the growth of the market. Diabetes & obesity are the major causes for cardiovascular diseases. Furthermore, increasing number of patients suffering from these diseases lead to increase in the prevalence of cardiovascular diseases, ultimately increase the demand for the cardiovascular devices which will fuel the growth of the market. However, growing Cardiovascular (CV) disease burden is the major factor contributing in the growth of the market and is likely to increase in coming years due to growing patient and geriatric populations.
Cardiovascular Ultrasound Market – Key Players
Some of the key players in this market are: GE Healthcare (U.S.), Philips healthcare (The Netherlands), Siemens Healthcare (Germany), Hitachi Medical Corporation (Japan), Toshiba Medical Systems Corporation (Japan)
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/1548
Global Cardiovascular Ultrasound Market – Competitive Analysis
June 2017 – Hitachi healthcare Americas introduced the “LISENDO 880,” new premium 2D and 3D cardiovascular ultrasound system at the American Society of Echocardiography 2017 in Baltimore, Maryland. AS per company reports, the advanced architecture of the LISENDO 880 offers state of the art probe technology for 2D and 3D imaging, a high-performance OLED display, premium image optimization parameters such as e-Focus and Pure Symphonic Architecture to capture the subtlest of changes and produce the highest-quality sound. There are many features of LISENDO 800 such as dynamic 3D evaluation, LVeFlow, Dual Gate Doppler, Eyeball EF, 2DTT, and FAM, provide solutions for the most difficult clinical challenges. Additionally, applications like VFM, eTracking and Wave Intensity move hemodynamic evaluations beyond the basics.
June 2014 – GE Healthcare, had received clearance from the Food and Drug Administration (FDA) for its Vivid T8TM cardiovascular ultrasound device. As per reports, GE had enhanced the reach of the Vivid T8 by combining the established cardiac imaging capabilities of GE Vivid systems with exceptional performance of the company’s LOGIQTM systems. The Vivid T8, cardiovascular ultrasound system is rugged, reliable, robust, and is affordable and convenient to use. It had been designed and rigorously tested for high reliability, the Vivid T8, mobile system intended for use in a variety of traditional as well as harsh, demanding environments. It delivers a hardy robustness that stands up to the challenges of even the busiest ultrasound imaging practices and clinical settings.
Cardiovascular Ultrasound Market – Segmentation
Global Cardiovascular Ultrasound Market has been segmented on the basis of type of imaging which includes transthoracic, trans esophageal, echocardiograms, stress, and abdominal vasculature ultrasound imaging, on the basis of imaging technology which includes 2D, 3D and Color Doppler. End user are hospitals and clinics, diagnostic centers and others.
Global Cardiovascular Ultrasound Market- Regional Analysis
Depending on geographic region, cardiovascular ultrasound market is segmented into four key regions: Americas, Europe, Asia-Pacific, and Middle East & Africa. Globally Americas hold the largest market share for cardiac rehabilitation devices. North American region is the leading market in the America region. Europe is the second-largest market globally for cardiac rehabilitation devices which is expected to continue its growth in the near future. Asia pacific region is expected to be fastest growing region in cardiac rehabilitation devices market. However, the Middle East & Africa holds the least share of the cardiovascular ultrasound imaging market due to less availability of funds, limited medical facilities, and deprived political conditions in Africa.
Browse Complete 80 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/cardiovascular-ultrasound-market-1548
Major Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope of the Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312